Association of recent HIV infection and in-utero HIV-1 transmission

AIDS

Volumn 25, Issue 11, 2011, Pages 1357-1364

  Taha, Taha E ^a   James, Maria M ^b   Hoover, Donald R ^c   Sun, Jin ^a   Laeyendecker, Oliver ^b,d   Mullis, Caroline E ^b   Kumwenda, Johnstone J ^e   Lingappa, Jairam R ^f   Auvert, Bertran ^g,h,i   Morrison, Charles S ^j   Mofensen, Lynne M ^k   Taylor, Allan ^l   Fowler, Mary G ^b   Kumenda, Newton I ^a   Eshleman, Susan H ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF MALAWI   (Malawi)

^f UNIVERSITY OF WASHINGTON   (United States)

^g CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j Clinical Sciences Division   (United States)

^k EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^l CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

HIV; incidence; Malawi; mother to child transmission; multiassay algorithm

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DELIVERY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; PARITY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ALGORITHMS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALAWI; ODDS RATIO; POST-EXPOSURE PROPHYLAXIS; PREGNANCY; RISK FACTORS; RNA, VIRAL; VIRAL LOAD; YOUNG ADULT;

EID: 79959973528     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283489d45     Document Type: Article

References (43)

1. Interagency Task Team on Prevention of HIV Infection in Pregnant Women M, and their Children, Guidance on global scale-up of the prevention of mother-to-child transmission of HIV. 2007. http://www.who.int/hiv/pub/ guidelines/pmtct- scaleup2007/en/index.html. [Accessed October 2010].
2. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340:585-588.
3. Liang K, Gui X, Zhang YZ, Zhuang K, Meyers K, Ho DD. A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis 2009; 200:682-686.
4. Lockman S, Creek T. Acute maternal HIV infection during pregnancy and breast-feeding: substantial risk to infants. J Infect Dis 2009; 200:667-669.
5. Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 2009; 23:1255-1259.
6. Lindback S, Karlsson AC, Mittler J, Blaxhult A, Carlsson M, Briheim G, et al. Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS 2000; 14:2283-2291.
7. Soogoor M, Daar ES. Primary human immunodeficiency virus type 1 infection. Curr HIV/AIDS Rep 2005; 2:55-60.
8. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997; 3:549-552. (Pubitemid 27198654)
9. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341:394-402. (Pubitemid 29362512)
10. John GC, Nduati R, Mbori-Ngacha D. Correlataes of mother-tochild human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001; 183:206-212. (Pubitemid 32066020)
11. Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, et al. Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. J Acquir Immune Defic Syndr 2009; 52:32-39.
12. Kumwenda J, Matchere F, Mataya R, Chen S, Mipando L, Li Q, et al. Coverage of highly active antiretroviral therapy among postpartum women in Malawi. Int J STDs AIDS 2011 (in press).
13. Quinn TC, Brookmeyer R, Kline R, Shepherd M, Paranjape R, Mehendale S, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14:2751-2757. (Pubitemid 32118729)
14. Gay CL, Mwapasa V, Murdoch DM, Kwiek JJ, Fiscus SA, Meshnick SR, et al. Acute HIV infection among pregnant women in Malawi. Diagn Microbiol Infect Dis 2010; 66:356-360.
15. Kharsany AB, Hancock N, Frohlich JA, Humphries HR, Abdool Karim SS, Abdool Karim Q. Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa. HIV Med 2010; 11:661-665.
16. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008; 13:pii:18966.
17. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 2009; 9:747-759.
18. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, et al. Estimating HIV incidence in populations: issues, challenges and the way forward. jHASE 2010; 2:7.
19. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, et al. The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital emergency department. J Acquir Immune Defic Syndr 2008; 48:211-215.
20. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, et al. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010; 53:496-499.
21. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004; 42:2623-2628. (Pubitemid 38747513)
22. Laeyendecker O, Oliver A, Neal J, Gamiel J, Krauss C, Eshleman SH, et al. Decreasing HIV incidence and prevalence at the Johns Hopkins emergency department with a concurrent increase of virally suppressed HIV-infected individuals. 16th Conference on Retroviruses and Opportunistic Infections; 2009; San Francisco, CA. Abstract # 1045.
23. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010; 24:2763-2771.
24. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, Rudolph D, et al. Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. 17th Conference on Retroviruses and Opportunistics Infections 2010; San Francisco, CA. Abstract #937.
25. Family Health International. Development of assays to measure HIV incidence: Meeting Proceedings. Chapel Hill, NC May 13-14, 2009. http://www.fhi.org/en/HIVAIDS/pub/meeting-reports/ HIV-inc-assays.htm 2009. [Accessed November 2010].
26. Laeyendecker O, Oliver A, Astemborski J, Owen M, Kirk G, Mehta S, et al. Improved precision of cross-sectional HIV incidence testing using a multiassay algorithm that includes BED and an avidity assay with modified assay cut-offs. 17th Conference on Retroviruses and Opportunistic Infections 2010; San Francisco, CA. Abstract #935.
27. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359:119-129. (Pubitemid 351962035)
28. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95. (Pubitemid 44912541)
29. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
30. Fiamma A, Lissouba P, Amy OE, Singh B, Laeyendecker O, Quinn TC, et al. Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265). BMC Infect Dis 2010; 10:137.
31. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010; 375:824-833.
32. Taha TE, Kumwenda NI, Gibbons A, Broadhead RL, Fiscus S, Lema V, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 2003; 362:1171-1177. (Pubitemid 37255341)
33. Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004; 292:202-209. (Pubitemid 38917997)
34. Hladik W, Olara D, Mermin J, Moore D, Were W, Alexander L, et al. Effect of CD4(R) T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses 2011 [Epub ahead of print] doi:10.1089/aid.2010.0347.
35. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007; 21:403-408.
36. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409. (Pubitemid 40563350)
37. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-693.
38. Sagar M, Laeyendecker O, Lee S, Gamiel J, Wawer MJ, Gray RH, et al. Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis 2009; 199:580-589.
39. Sagar M. HIV-1 transmission biology: selection and characteristics of infecting viruses. J Infect Dis 2010; 202 (Suppl 2):S289-S296.
40. Gray GE, Tiemessen CT, de Bruyn G. Immune-based prevention of mother-to-child HIV-1 transmission. Curr Opin Mol Ther 2007; 9:168-175. (Pubitemid 46623949)
41. Lehman DA, Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007; 17:381-403. (Pubitemid 350144563)
42. Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev 2009; 11:140-156.
43. Bulterys M, Chao A, Habimana P, Dushimimana A, Nawrocki P, Saah A. Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS 1994; 8:1585-1591. (Pubitemid 24335096)